TF 0075
Alternative Names: TF-0075Latest Information Update: 13 Sep 2023
Price :
$50 *
At a glance
- Originator Techfields Pharma
- Class Antibacterials
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 13 Sep 2023 Discontinued - Preclinical for Bacterial infections in USA (unspecified route) (Techfields Pharma pipeline; September 2023)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Bacterial-infections in USA
- 29 Jul 2016 Preclinical trials in Bacterial infections in USA (unspecified route)